PPD CorEvitas Neurology Registries
PPD™ CorEvitas™ Clinical Registries track information about the health status of patients and the care they receive, bringing together large regulatory-grade proprietary data sets to analyze patterns in treatment and outcomes, informing best practices and treatment decisions.
Developed and maintained under the guidance of scientific advisors who are preeminent experts in their fields, these registries feature exceptional data completeness and scientific rigor.
Now enrolling qualified sites for our neurology registries!
CorEvitas Multiple Sclerosis (MS) Registry
Leverage information from this prospective, multi-site, observational study to obtain real-world data and evidence on the comparative effectiveness and safety of approved therapies in patients with MS in the U.S. In addition to analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices, this registry’s data provide a wide range of key outcome measures and opportunities for research.
Our extensive MS Registry comprises
Study visits
Patients
Neurologists
Examples of the robust outcome measures collected in the CorEvitas MS Registry
Clinician-Reported Outcomes
- Relapse rate (12 and 24 months)
- Timed 25-foot walk (T25-FW)
- 9-Hole peg test (9-HPT)
- Symbol digit modalities test (SDMT)
- Clinical global impression scale (CGI)
Patient-Reported Outcomes
- MS Disability Score: Patient Determined Disease Steps (PDDS)
- Depression Outcome: Patient Health Questionnaire-2 (PHQ-2)
- Multiple Sclerosis Impact Scale (MSIS-29)
- Work Productivity and Activity Impairment (WPAI)
- Morning Stiffness Visual Analogue Scale
- Fatigue (shortened, modified Fatigue Impact Scale)
- Patient Global Impression of Change (PGIC)
- Pain Numerical Rating Scale
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes
CorEvitas SPHERES Neuromyelitis Optica Spectrum Disorder (NMOSD) Registry
Developed in partnership with the Guthy Jackson Charitable Foundation, the CorEvitas NMOSD Registry provides robust real-world data to improve understanding of NMOSD disease and treatment. These insights help inform research decisions that will improve patients’ lives.
Our NMOSD Registry comprises
Study visits
Patients
Neurologists
Examples of the robust outcome measures collected in the CorEvitas NMOSD Registry
Disease characteristics
- Primary Diagnosis
- Year of onset and diagnosis of NMOSD
- Details of neurological episodes (initial and subsequent relapses)
- 2015 IPND international consensus diagnostic criteria characteristics
- Serology Status (AQP4, MOG)
- EDSS (expanded disability status scale) Step Score
- Montreal Cognitive Assessment (MoCA)
- History of Infections
- Comorbidity and Medical History
Patient-Reported Outcomes
- Modified Fatigue Impact Scale (MFIS)
- PainDETECT Questionnaire (PD-Q)
- EuroQol Visual Analogue Scale (EQ-VAS)
- 5-level EQ-5D version (EQ-5D-5L)
- Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2)
- Pain Severity Numeric Rating Scale
- Patient Health Questionnaire-2 (PHQ-2)
- Visual Function Questionnaire – Utility Index (VFQ-UI)
Make these data work for you.
Join our Registry Investigator Network to improve patient health outcomes